Terminated PHASE4 INTERVENTIONAL 2-arm NCT00428025

Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients

Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients: A Prospective, Randomized, Double Blind, Placebo Controlled Trial.

Sponsor: Queen's University

Conditions Pancreatitis

Interventions diclofenac placebo

Updated 7 times since 2017 Last updated: Sep 18, 2015 Started: Oct 31, 2006 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow recruitment

Other terminated trials from Queen's University

See all terminations from Queen's University

Other Pancreatitis trials with similar outcome

Browse all Pancreatitis trials

This PHASE4 trial investigates Pancreatitis and is currently terminated or withdrawn. Queen's University leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Jun 2025 — Present [monthly]

Terminated PHASE4
Apr 2025 — Jun 2025 [monthly]

Terminated PHASE4
Sep 2024 — Apr 2025 [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Queen's University

Data source: Queen's University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kingston, Canada